Industry Research Reports
Home > Reports > Service & Software > CRISPR Screening Library - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
CRISPR Screening Library - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
Industry: Service & Software
Published Date: 2026-07-19
Pages: 120 Pages
Report ld: 6978673
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
CRISPR Screening Library Market Size(US$)
CAGR 2026-2032
15.0%
Market Size,2032
USD 583
Million
Market Snapshot
Market Size in 2026 (Value)
US$ 252 million
Market Forecast in 2032(Value)
US$ 583 million
CAGR
15.0%
Years Considered
2021-2032
Base Year
2026
Forecast Period
2026-2032
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for CRISPR Screening Library was estimated to be worth US$ 218 million in 2025 and is projected to reach US$ 583 million, growing at a CAGR of 15.0% from 2026 to 2032.
CRISPR screening libraries are high-throughput gene perturbation products comprising large sets of designed and quality-controlled guide RNA sequences supplied as vectors, viral particles, synthetic RNA, or other ready-to-use formats. They support gene knockout, interference, activation, or precision editing in cell populations, with phenotypic selection and sequencing used to identify key genes, pathways, and drug targets. Product value is mainly determined by target coverage, guide design quality, library uniformity, off-target control, delivery titer, and compatibility with downstream platforms. The blended gross margin is approximately 55%.
Demand for validated and reproducible functional-genomics evidence is rising across drug research, moving CRISPR screening libraries from specialist academic tools toward routine use in target discovery, mechanism studies, resistance analysis, and cell therapy engineering. Combined workflows that use genome-wide primary screens followed by focused validation screens are supporting growth in both catalog and custom libraries across oncology, immunology, metabolism, and rare-disease research.
Product development is expanding beyond conventional knockout libraries into CRISPR interference, CRISPR activation, base editing, and single-cell perturbation workflows. Suppliers increasingly compete on guide design algorithms, library uniformity, off-target control, viral titer, lot-level quality control, and compatibility with high-content imaging, cell sorting, and single-cell sequencing platforms. Integrated offerings that combine design, construction, packaging, and data analysis are becoming more important.
North America and Europe remain the main markets for premium products and pharmaceutical customers, while demand in China is being supported by innovative drug programs, cell therapy development, and expansion of research platforms. Key risks include cell-model-specific delivery performance, essential-gene bias, insufficient screen coverage, reproducibility, intellectual-property constraints, and biosafety requirements. Opportunities are concentrated in focused libraries, delivery to difficult cell models, single-cell-compatible libraries, and standardized analysis workflows.
This report provides a comprehensive view of the global market for CRISPR Screening Library, covering total sales revenue, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.
The CRISPR Screening Library market size, estimations, and forecasts are presented in terms of sales revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding CRISPR Screening Library.
MARKET SEGMENTATION
By Company
- Thermo Fisher Scientific
- Merck
- Revvity
- Integrated DNA Technologies
- Synthego
- GenScript
- Agilent Technologies
- Twist Bioscience
- Cellecta
- VectorBuilder
- Ubigene
- GeneCopoeia
- GeneChem
- Applied Biological Materials
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- CRISPR Knockout Libraries
- CRISPR Interference Libraries
- CRISPR Activation Libraries
- Base Editing Libraries
- Prime Editing Libraries
- Other CRISPR Screening Libraries
Segment by Application
- Drug Target Discovery and Validation
- Drug Resistance and Sensitivity Screening
- Synthetic Lethality and Combination Therapy
- Functional Genomics and Pathway Analysis
- Immuno-Oncology and Cell Therapy Engineering
- Disease Modeling and Phenotype Screening
Segment by Category
- Up to 5,000 Guides
- 5,001–25,000 Guides
- 25,001–50,000 Guides
- More than 50,000 Guides
Segment by Division
- Pooled Libraries
- Arrayed Libraries
CHAPTER OUTLINE
Chapter 1: Introduces the scope of the report and the global market size (value). It also summarizes market dynamics and recent developments; identifies key drivers and restraints; outlines challenges and risks for players; reviews relevant industry policies.
Chapter 2: Provides a detailed analysis of the CRISPR Screening Library companies' competitive landscape—including revenue shares, recent development plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents CRISPR Screening Library revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents CRISPR Screening Library revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product revenue, gross margin, product portfolios, recent developments, etc.
Chapter 8: Analysis of Value Chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 CRISPR Screening Library Product Introduction
1.2 Global CRISPR Screening Library Market Size Forecast (2021–2032)
1.3 CRISPR Screening Library Market Trends & Drivers
1.3.1 CRISPR Screening Library Industry Trends
1.3.2 CRISPR Screening Library Market Drivers & Opportunities
1.3.3 CRISPR Screening Library Market Challenges
1.3.4 CRISPR Screening Library Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global CRISPR Screening Library Players Revenue Ranking (2025)
2.2 Global CRISPR Screening Library Revenue by Company (2021–2026)
2.3 Key Companies’ R&D and Operations Footprint and Headquarters
2.4 Key Companies CRISPR Screening Library Product Offerings
2.5 Key Companies General Availability (GA) Timeline for CRISPR Screening Library
2.6 CRISPR Screening Library Market Competitive Analysis
2.6.1 CRISPR Screening Library Market Concentration Rate (2021–2026)
2.6.2 Top 5 and Top 10 Global Companies by CRISPR Screening Library Revenue in 2025
2.6.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on CRISPR Screening Library revenue, 2025
2.7 Mergers & Acquisitions and Expansion
3 Segmentation CRISPR Screening Library Market Classification
3.1 Introduction by Type
3.1.1 CRISPR Knockout Libraries
3.1.2 CRISPR Interference Libraries
3.1.3 CRISPR Activation Libraries
3.1.4 Base Editing Libraries
3.1.5 Prime Editing Libraries
3.1.6 Other CRISPR Screening Libraries
3.1.7 Global CRISPR Screening Library Sales Value by Type
3.1.7.1 Global CRISPR Screening Library Sales Value by Type (2021 vs 2025 vs 2032)
3.1.7.2 Global CRISPR Screening Library Sales Value, by Type (2021–2032)
3.1.7.3 Global CRISPR Screening Library Sales Value, by Type (%), 2021–2032
3.2 Introduction by Guide Count
3.2.1 Up to 5,000 Guides
3.2.2 5,001–25,000 Guides
3.2.3 25,001–50,000 Guides
3.2.4 More than 50,000 Guides
3.2.5 Global CRISPR Screening Library Sales Value by Guide Count
3.2.5.1 Global CRISPR Screening Library Sales Value by Guide Count (2021 vs 2025 vs 2032)
3.2.5.2 Global CRISPR Screening Library Sales Value, by Guide Count (2021–2032)
3.2.5.3 Global CRISPR Screening Library Sales Value, by Guide Count (%), 2021–2032
3.3 Introduction by Library Organization
3.3.1 Pooled Libraries
3.3.2 Arrayed Libraries
3.3.3 Global CRISPR Screening Library Sales Value by Library Organization
3.3.3.1 Global CRISPR Screening Library Sales Value by Library Organization (2021 vs 2025 vs 2032)
3.3.3.2 Global CRISPR Screening Library Sales Value, by Library Organization (2021–2032)
3.3.3.3 Global CRISPR Screening Library Sales Value, by Library Organization (%), 2021–2032
3.4 Introduction by Delivery Format
3.4.1 Oligo Pool Libraries
3.4.2 Plasmid DNA Libraries
3.4.3 Lentiviral Particle Libraries
3.4.4 Synthetic Guide RNA Libraries
3.4.5 Engineered Cell Libraries
3.4.6 Global CRISPR Screening Library Sales Value by Delivery Format
3.4.6.1 Global CRISPR Screening Library Sales Value by Delivery Format (2021 vs 2025 vs 2032)
3.4.6.2 Global CRISPR Screening Library Sales Value, by Delivery Format (2021–2032)
3.4.6.3 Global CRISPR Screening Library Sales Value, by Delivery Format (%), 2021–2032
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Drug Target Discovery and Validation
4.1.2 Drug Resistance and Sensitivity Screening
4.1.3 Synthetic Lethality and Combination Therapy
4.1.4 Functional Genomics and Pathway Analysis
4.1.5 Immuno-Oncology and Cell Therapy Engineering
4.1.6 Disease Modeling and Phenotype Screening
4.2 Global CRISPR Screening Library Sales Value by Application
4.2.1 Global CRISPR Screening Library Sales Value by Application (2021 vs 2025 vs 2032)
4.2.2 Global CRISPR Screening Library Sales Value by Application (2021–2032)
4.2.3 Global CRISPR Screening Library Sales Value by Application (%), 2021–2032
5 Segmentation by Region
5.1 Global CRISPR Screening Library Sales Value by Region
5.1.1 Global CRISPR Screening Library Sales Value by Region: 2021 vs 2025 vs 2032
5.1.2 Global CRISPR Screening Library Sales Value by Region (2021–2026)
5.1.3 Global CRISPR Screening Library Sales Value by Region (2027–2032)
5.1.4 Global CRISPR Screening Library Sales Value by Region (%), 2021–2032
5.2 North America
5.2.1 North America CRISPR Screening Library Sales Value, 2021–2032
5.2.2 North America CRISPR Screening Library Sales Value by Country (%), 2025 vs 2032
5.3 Europe
5.3.1 Europe CRISPR Screening Library Sales Value, 2021–2032
5.3.2 Europe CRISPR Screening Library Sales Value by Country (%), 2025 vs 2032
5.4 Asia Pacific
5.4.1 Asia Pacific CRISPR Screening Library Sales Value, 2021–2032
5.4.2 Asia Pacific CRISPR Screening Library Sales Value by Subregion (%), 2025 vs 2032
5.5 South America
5.5.1 South America CRISPR Screening Library Sales Value, 2021–2032
5.5.2 South America CRISPR Screening Library Sales Value by Country (%), 2025 vs 2032
5.6 Middle East & Africa
5.6.1 Middle East & Africa CRISPR Screening Library Sales Value, 2021–2032
5.6.2 Middle East & Africa CRISPR Screening Library Sales Value by Country (%), 2025 vs 2032
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions CRISPR Screening Library Sales Value Growth Trends, 2021 vs 2025 vs 2032
6.2 Key Countries/Regions CRISPR Screening Library Sales Value, 2021–2032
6.3 United States
6.3.1 United States CRISPR Screening Library Sales Value, 2021–2032
6.3.2 United States CRISPR Screening Library Sales Value by Type (%), 2025 vs 2032
6.3.3 United States CRISPR Screening Library Sales Value by Application, 2025 vs 2032
6.4 Europe
6.4.1 Europe CRISPR Screening Library Sales Value, 2021–2032
6.4.2 Europe CRISPR Screening Library Sales Value by Type (%), 2025 vs 2032
6.4.3 Europe CRISPR Screening Library Sales Value by Application, 2025 vs 2032
6.5 China
6.5.1 China CRISPR Screening Library Sales Value, 2021–2032
6.5.2 China CRISPR Screening Library Sales Value by Type (%), 2025 vs 2032
6.5.3 China CRISPR Screening Library Sales Value by Application, 2025 vs 2032
6.6 Japan
6.6.1 Japan CRISPR Screening Library Sales Value, 2021–2032
6.6.2 Japan CRISPR Screening Library Sales Value by Type (%), 2025 vs 2032
6.6.3 Japan CRISPR Screening Library Sales Value by Application, 2025 vs 2032
6.7 South Korea
6.7.1 South Korea CRISPR Screening Library Sales Value, 2021–2032
6.7.2 South Korea CRISPR Screening Library Sales Value by Type (%), 2025 vs 2032
6.7.3 South Korea CRISPR Screening Library Sales Value by Application, 2025 vs 2032
6.8 Southeast Asia
6.8.1 Southeast Asia CRISPR Screening Library Sales Value, 2021–2032
6.8.2 Southeast Asia CRISPR Screening Library Sales Value by Type (%), 2025 vs 2032
6.8.3 Southeast Asia CRISPR Screening Library Sales Value by Application, 2025 vs 2032
6.9 India
6.9.1 India CRISPR Screening Library Sales Value, 2021–2032
6.9.2 India CRISPR Screening Library Sales Value by Type (%), 2025 vs 2032
6.9.3 India CRISPR Screening Library Sales Value by Application, 2025 vs 2032
7 Company Profiles
7.1 Thermo Fisher Scientific
7.1.1 Thermo Fisher Scientific Profile
7.1.2 Thermo Fisher Scientific Main Business
7.1.3 Thermo Fisher Scientific CRISPR Screening Library Products, Services, and Solutions
7.1.4 Thermo Fisher Scientific CRISPR Screening Library Revenue (US$ Million), 2021–2026
7.1.5 Thermo Fisher Scientific Recent Developments
7.2 Merck
7.2.1 Merck Profile
7.2.2 Merck Main Business
7.2.3 Merck CRISPR Screening Library Products, Services, and Solutions
7.2.4 Merck CRISPR Screening Library Revenue (US$ Million), 2021–2026
7.2.5 Merck Recent Developments
7.3 Revvity
7.3.1 Revvity Profile
7.3.2 Revvity Main Business
7.3.3 Revvity CRISPR Screening Library Products, Services, and Solutions
7.3.4 Revvity CRISPR Screening Library Revenue (US$ Million), 2021–2026
7.3.5 Revvity Recent Developments
7.4 Integrated DNA Technologies
7.4.1 Integrated DNA Technologies Profile
7.4.2 Integrated DNA Technologies Main Business
7.4.3 Integrated DNA Technologies CRISPR Screening Library Products, Services, and Solutions
7.4.4 Integrated DNA Technologies CRISPR Screening Library Revenue (US$ Million), 2021–2026
7.4.5 Integrated DNA Technologies Recent Developments
7.5 Synthego
7.5.1 Synthego Profile
7.5.2 Synthego Main Business
7.5.3 Synthego CRISPR Screening Library Products, Services, and Solutions
7.5.4 Synthego CRISPR Screening Library Revenue (US$ Million), 2021–2026
7.5.5 Synthego Recent Developments
7.6 GenScript
7.6.1 GenScript Profile
7.6.2 GenScript Main Business
7.6.3 GenScript CRISPR Screening Library Products, Services, and Solutions
7.6.4 GenScript CRISPR Screening Library Revenue (US$ Million), 2021–2026
7.6.5 GenScript Recent Developments
7.7 Agilent Technologies
7.7.1 Agilent Technologies Profile
7.7.2 Agilent Technologies Main Business
7.7.3 Agilent Technologies CRISPR Screening Library Products, Services, and Solutions
7.7.4 Agilent Technologies CRISPR Screening Library Revenue (US$ Million), 2021–2026
7.7.5 Agilent Technologies Recent Developments
7.8 Twist Bioscience
7.8.1 Twist Bioscience Profile
7.8.2 Twist Bioscience Main Business
7.8.3 Twist Bioscience CRISPR Screening Library Products, Services, and Solutions
7.8.4 Twist Bioscience CRISPR Screening Library Revenue (US$ Million), 2021–2026
7.8.5 Twist Bioscience Recent Developments
7.9 Cellecta
7.9.1 Cellecta Profile
7.9.2 Cellecta Main Business
7.9.3 Cellecta CRISPR Screening Library Products, Services, and Solutions
7.9.4 Cellecta CRISPR Screening Library Revenue (US$ Million), 2021–2026
7.9.5 Cellecta Recent Developments
7.10 VectorBuilder
7.10.1 VectorBuilder Profile
7.10.2 VectorBuilder Main Business
7.10.3 VectorBuilder CRISPR Screening Library Products, Services, and Solutions
7.10.4 VectorBuilder CRISPR Screening Library Revenue (US$ Million), 2021–2026
7.10.5 VectorBuilder Recent Developments
7.11 Ubigene
7.11.1 Ubigene Profile
7.11.2 Ubigene Main Business
7.11.3 Ubigene CRISPR Screening Library Products, Services, and Solutions
7.11.4 Ubigene CRISPR Screening Library Revenue (US$ Million), 2021–2026
7.11.5 Ubigene Recent Developments
7.12 GeneCopoeia
7.12.1 GeneCopoeia Profile
7.12.2 GeneCopoeia Main Business
7.12.3 GeneCopoeia CRISPR Screening Library Products, Services, and Solutions
7.12.4 GeneCopoeia CRISPR Screening Library Revenue (US$ Million), 2021–2026
7.12.5 GeneCopoeia Recent Developments
7.13 GeneChem
7.13.1 GeneChem Profile
7.13.2 GeneChem Main Business
7.13.3 GeneChem CRISPR Screening Library Products, Services, and Solutions
7.13.4 GeneChem CRISPR Screening Library Revenue (US$ Million), 2021–2026
7.13.5 GeneChem Recent Developments
7.14 Applied Biological Materials
7.14.1 Applied Biological Materials Profile
7.14.2 Applied Biological Materials Main Business
7.14.3 Applied Biological Materials CRISPR Screening Library Products, Services, and Solutions
7.14.4 Applied Biological Materials CRISPR Screening Library Revenue (US$ Million), 2021–2026
7.14.5 Applied Biological Materials Recent Developments
8 Industry Chain Analysis
8.1 CRISPR Screening Library Value Chain
8.2 CRISPR Screening Library Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Key Suppliers of Raw Materials
8.2.3 Cost Structure
8.3 Midstream Analysis
8.4 Downstream (Customer) Analysis
8.5 Sales Model and Sales Channelss
8.5.1 CRISPR Screening Library Sales Model
8.5.2 Sales Channels
8.5.3 CRISPR Screening Library Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. CRISPR Screening Library Market Trends
Table 2. CRISPR Screening Library Market Drivers & Opportunities
Table 3. CRISPR Screening Library Market Challenges
Table 4. CRISPR Screening Library Market Restraints
Table 5. Global CRISPR Screening Library Revenue by Company (US$ Million), 2021–2026
Table 6. Global CRISPR Screening Library Revenue Market Share by Company (2021–2026)
Table 7. Key Companies’ R&D and Operations Footprint and Headquarters
Table 8. Key Companies CRISPR Screening Library Product Type
Table 9. Key Companies General Availability (GA) Timeline for CRISPR Screening Library
Table 10. Global CRISPR Screening Library Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on CRISPR Screening Library revenue, 2025
Table 12. Mergers & Acquisitions and Expansion Plans
Table 13. Global CRISPR Screening Library Sales Value by Type: 2021 vs 2025 vs 2032 (US$ Million)
Table 14. Global CRISPR Screening Library Sales Value by Type (US$ Million), 2021–2026
Table 15. Global CRISPR Screening Library Sales Value by Type (US$ Million), 2027–2032
Table 16. Global CRISPR Screening Library Sales Market Share in Value by Type (2021–2026)
Table 17. Global CRISPR Screening Library Sales Market Share in Value by Type (2027–2032)
Table 18. Global CRISPR Screening Library Sales Value by Guide Count: 2021 vs 2025 vs 2032 (US$ Million)
Table 19. Global CRISPR Screening Library Sales Value by Guide Count (US$ Million), 2021–2026
Table 20. Global CRISPR Screening Library Sales Value by Guide Count (US$ Million), 2027–2032
Table 21. Global CRISPR Screening Library Sales Market Share in Value by Guide Count (2021–2026)
Table 22. Global CRISPR Screening Library Sales Market Share in Value by Guide Count (2027–2032)
Table 23. Global CRISPR Screening Library Sales Value by Library Organization: 2021 vs 2025 vs 2032 (US$ Million)
Table 24. Global CRISPR Screening Library Sales Value by Library Organization (US$ Million), 2021–2026
Table 25. Global CRISPR Screening Library Sales Value by Library Organization (US$ Million), 2027–2032
Table 26. Global CRISPR Screening Library Sales Market Share in Value by Library Organization (2021–2026)
Table 27. Global CRISPR Screening Library Sales Market Share in Value by Library Organization (2027–2032)
Table 28. Global CRISPR Screening Library Sales Value by Delivery Format: 2021 vs 2025 vs 2032 (US$ Million)
Table 29. Global CRISPR Screening Library Sales Value by Delivery Format (US$ Million), 2021–2026
Table 30. Global CRISPR Screening Library Sales Value by Delivery Format (US$ Million), 2027–2032
Table 31. Global CRISPR Screening Library Sales Market Share in Value by Delivery Format (2021–2026)
Table 32. Global CRISPR Screening Library Sales Market Share in Value by Delivery Format (2027–2032)
Table 33. Global CRISPR Screening Library Sales Value by Application: 2021 vs 2025 vs 2032 (US$ Million)
Table 34. Global CRISPR Screening Library Sales Value by Application (US$ Million), 2021–2026
Table 35. Global CRISPR Screening Library Sales Value by Application (US$ Million), 2027–2032
Table 36. Global CRISPR Screening Library Sales Market Share in Value by Application (2021–2026)
Table 37. Global CRISPR Screening Library Sales Market Share in Value by Application (2027–2032)
Table 38. Global CRISPR Screening Library Sales Value by Region, (US$ Million), 2021 vs 2025 vs 2032
Table 39. Global CRISPR Screening Library Sales Value by Region (US$ Million), 2021–2026
Table 40. Global CRISPR Screening Library Sales Value by Region (US$ Million), 2027–2032
Table 41. Global CRISPR Screening Library Sales Value by Region (%), 2021–2026
Table 42. Global CRISPR Screening Library Sales Value by Region (%), 2027–2032
Table 43. Key Countries/Regions CRISPR Screening Library Sales Value Growth Trends, (US$ Million): 2021 vs 2025 vs 2032
Table 44. Key Countries/Regions CRISPR Screening Library Sales Value, (US$ Million), 2021–2026
Table 45. Key Countries/Regions CRISPR Screening Library Sales Value, (US$ Million), 2027–2032
Table 46. Thermo Fisher Scientific Basic Information List
Table 47. Thermo Fisher Scientific Description and Business Overview
Table 48. Thermo Fisher Scientific CRISPR Screening Library Products, Services, and Solutions
Table 49. Revenue (US$ Million) in CRISPR Screening Library Business of Thermo Fisher Scientific (2021–2026)
Table 50. Thermo Fisher Scientific Recent Developments
Table 51. Merck Basic Information List
Table 52. Merck Description and Business Overview
Table 53. Merck CRISPR Screening Library Products, Services, and Solutions
Table 54. Revenue (US$ Million) in CRISPR Screening Library Business of Merck (2021–2026)
Table 55. Merck Recent Developments
Table 56. Revvity Basic Information List
Table 57. Revvity Description and Business Overview
Table 58. Revvity CRISPR Screening Library Products, Services, and Solutions
Table 59. Revenue (US$ Million) in CRISPR Screening Library Business of Revvity (2021–2026)
Table 60. Revvity Recent Developments
Table 61. Integrated DNA Technologies Basic Information List
Table 62. Integrated DNA Technologies Description and Business Overview
Table 63. Integrated DNA Technologies CRISPR Screening Library Products, Services, and Solutions
Table 64. Revenue (US$ Million) in CRISPR Screening Library Business of Integrated DNA Technologies (2021–2026)
Table 65. Integrated DNA Technologies Recent Developments
Table 66. Synthego Basic Information List
Table 67. Synthego Description and Business Overview
Table 68. Synthego CRISPR Screening Library Products, Services, and Solutions
Table 69. Revenue (US$ Million) in CRISPR Screening Library Business of Synthego (2021–2026)
Table 70. Synthego Recent Developments
Table 71. GenScript Basic Information List
Table 72. GenScript Description and Business Overview
Table 73. GenScript CRISPR Screening Library Products, Services, and Solutions
Table 74. Revenue (US$ Million) in CRISPR Screening Library Business of GenScript (2021–2026)
Table 75. GenScript Recent Developments
Table 76. Agilent Technologies Basic Information List
Table 77. Agilent Technologies Description and Business Overview
Table 78. Agilent Technologies CRISPR Screening Library Products, Services, and Solutions
Table 79. Revenue (US$ Million) in CRISPR Screening Library Business of Agilent Technologies (2021–2026)
Table 80. Agilent Technologies Recent Developments
Table 81. Twist Bioscience Basic Information List
Table 82. Twist Bioscience Description and Business Overview
Table 83. Twist Bioscience CRISPR Screening Library Products, Services, and Solutions
Table 84. Revenue (US$ Million) in CRISPR Screening Library Business of Twist Bioscience (2021–2026)
Table 85. Twist Bioscience Recent Developments
Table 86. Cellecta Basic Information List
Table 87. Cellecta Description and Business Overview
Table 88. Cellecta CRISPR Screening Library Products, Services, and Solutions
Table 89. Revenue (US$ Million) in CRISPR Screening Library Business of Cellecta (2021–2026)
Table 90. Cellecta Recent Developments
Table 91. VectorBuilder Basic Information List
Table 92. VectorBuilder Description and Business Overview
Table 93. VectorBuilder CRISPR Screening Library Products, Services, and Solutions
Table 94. Revenue (US$ Million) in CRISPR Screening Library Business of VectorBuilder (2021–2026)
Table 95. VectorBuilder Recent Developments
Table 96. Ubigene Basic Information List
Table 97. Ubigene Description and Business Overview
Table 98. Ubigene CRISPR Screening Library Products, Services, and Solutions
Table 99. Revenue (US$ Million) in CRISPR Screening Library Business of Ubigene (2021–2026)
Table 100. Ubigene Recent Developments
Table 101. GeneCopoeia Basic Information List
Table 102. GeneCopoeia Description and Business Overview
Table 103. GeneCopoeia CRISPR Screening Library Products, Services, and Solutions
Table 104. Revenue (US$ Million) in CRISPR Screening Library Business of GeneCopoeia (2021–2026)
Table 105. GeneCopoeia Recent Developments
Table 106. GeneChem Basic Information List
Table 107. GeneChem Description and Business Overview
Table 108. GeneChem CRISPR Screening Library Products, Services, and Solutions
Table 109. Revenue (US$ Million) in CRISPR Screening Library Business of GeneChem (2021–2026)
Table 110. GeneChem Recent Developments
Table 111. Applied Biological Materials Basic Information List
Table 112. Applied Biological Materials Description and Business Overview
Table 113. Applied Biological Materials CRISPR Screening Library Products, Services, and Solutions
Table 114. Revenue (US$ Million) in CRISPR Screening Library Business of Applied Biological Materials (2021–2026)
Table 115. Applied Biological Materials Recent Developments
Table 116. Revenue (US$ Million) in CRISPR Screening Library Business of Company 40 (2021–2026)
Table 117. Company 40 Recent Developments
Table 118. Key Raw Materials Lists
Table 119. Key Suppliers of Raw Materials Lists
Table 120. CRISPR Screening Library Downstream Customers
Table 121. CRISPR Screening Library Distributors List
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
List of Figures
Figure 1. CRISPR Screening Library Product Picture
Figure 2. Global CRISPR Screening Library Sales Value, 2021 vs 2025 vs 2032 (US$ Million)
Figure 3. Global CRISPR Screening Library Sales Value (US$ Million), 2021–2032
Figure 4. CRISPR Screening Library Report Years Considered
Figure 5. Global CRISPR Screening Library Players Revenue Ranking (US$ Million), 2025
Figure 6. The 5 and 10 Largest Companies in the World: Market Share by CRISPR Screening Library Revenue in 2025
Figure 7. CRISPR Screening Library Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 8. CRISPR Knockout Libraries Picture
Figure 9. CRISPR Interference Libraries Picture
Figure 10. CRISPR Activation Libraries Picture
Figure 11. Base Editing Libraries Picture
Figure 12. Prime Editing Libraries Picture
Figure 13. Other CRISPR Screening Libraries Picture
Figure 14. Global CRISPR Screening Library Sales Value by Type (US$ Million), 2021 vs 2025 vs 2032
Figure 15. Global CRISPR Screening Library Sales Value Market Share by Type, 2025 & 2032
Figure 16. Up to 5,000 Guides Picture
Figure 17. 5,001–25,000 Guides Picture
Figure 18. 25,001–50,000 Guides Picture
Figure 19. More than 50,000 Guides Picture
Figure 20. Global CRISPR Screening Library Sales Value by Guide Count (US$ Million), 2021 vs 2025 vs 2032
Figure 21. Global CRISPR Screening Library Sales Value Market Share by Guide Count, 2025 & 2032
Figure 22. Pooled Libraries Picture
Figure 23. Arrayed Libraries Picture
Figure 24. Global CRISPR Screening Library Sales Value by Library Organization (US$ Million), 2021 vs 2025 vs 2032
Figure 25. Global CRISPR Screening Library Sales Value Market Share by Library Organization, 2025 & 2032
Figure 26. Oligo Pool Libraries Picture
Figure 27. Plasmid DNA Libraries Picture
Figure 28. Lentiviral Particle Libraries Picture
Figure 29. Synthetic Guide RNA Libraries Picture
Figure 30. Engineered Cell Libraries Picture
Figure 31. Global CRISPR Screening Library Sales Value by Delivery Format (US$ Million), 2021 vs 2025 vs 2032
Figure 32. Global CRISPR Screening Library Sales Value Market Share by Delivery Format, 2025 & 2032
Figure 33. Product Picture of Drug Target Discovery and Validation
Figure 34. Product Picture of Drug Resistance and Sensitivity Screening
Figure 35. Product Picture of Synthetic Lethality and Combination Therapy
Figure 36. Product Picture of Functional Genomics and Pathway Analysis
Figure 37. Product Picture of Immuno-Oncology and Cell Therapy Engineering
Figure 38. Product Picture of Disease Modeling and Phenotype Screening
Figure 39. Global CRISPR Screening Library Sales Value by Application (US$ Million), 2021 vs 2025 vs 2032
Figure 40. Global CRISPR Screening Library Sales Value Market Share by Application, 2025 & 2032
Figure 41. North America CRISPR Screening Library Sales Value (US$ Million), 2021–2032
Figure 42. North America CRISPR Screening Library Sales Value by Country (%), 2025 vs 2032
Figure 43. Europe CRISPR Screening Library Sales Value (US$ Million), 2021–2032
Figure 44. Europe CRISPR Screening Library Sales Value by Country (%), 2025 vs 2032
Figure 45. Asia Pacific CRISPR Screening Library Sales Value (US$ Million), 2021–2032
Figure 46. Asia Pacific CRISPR Screening Library Sales Value by Subregion (%), 2025 vs 2032
Figure 47. South America CRISPR Screening Library Sales Value (US$ Million), 2021–2032
Figure 48. South America CRISPR Screening Library Sales Value by Country (%), 2025 vs 2032
Figure 49. Middle East & Africa CRISPR Screening Library Sales Value (US$ Million), 2021–2032
Figure 50. Middle East & Africa CRISPR Screening Library Sales Value by Country (%), 2025 vs 2032
Figure 51. Key Countries/Regions CRISPR Screening Library Sales Value (%), 2021–2032
Figure 52. United States CRISPR Screening Library Sales Value (US$ Million), 2021–2032
Figure 53. United States CRISPR Screening Library Sales Value by Type (%), 2025 vs 2032
Figure 54. United States CRISPR Screening Library Sales Value by Application (%), 2025 vs 2032
Figure 55. Europe CRISPR Screening Library Sales Value (US$ Million), 2021–2032
Figure 56. Europe CRISPR Screening Library Sales Value by Type (%), 2025 vs 2032
Figure 57. Europe CRISPR Screening Library Sales Value by Application (%), 2025 vs 2032
Figure 58. China CRISPR Screening Library Sales Value (US$ Million), 2021–2032
Figure 59. China CRISPR Screening Library Sales Value by Type (%), 2025 vs 2032
Figure 60. China CRISPR Screening Library Sales Value by Application (%), 2025 vs 2032
Figure 61. Japan CRISPR Screening Library Sales Value (US$ Million), 2021–2032
Figure 62. Japan CRISPR Screening Library Sales Value by Type (%), 2025 vs 2032
Figure 63. Japan CRISPR Screening Library Sales Value by Application (%), 2025 vs 2032
Figure 64. South Korea CRISPR Screening Library Sales Value (US$ Million), 2021–2032
Figure 65. South Korea CRISPR Screening Library Sales Value by Type (%), 2025 vs 2032
Figure 66. South Korea CRISPR Screening Library Sales Value by Application (%), 2025 vs 2032
Figure 67. Southeast Asia CRISPR Screening Library Sales Value (US$ Million), 2021–2032
Figure 68. Southeast Asia CRISPR Screening Library Sales Value by Type (%), 2025 vs 2032
Figure 69. Southeast Asia CRISPR Screening Library Sales Value by Application (%), 2025 vs 2032
Figure 70. India CRISPR Screening Library Sales Value (US$ Million), 2021–2032
Figure 71. India CRISPR Screening Library Sales Value by Type (%), 2025 vs 2032
Figure 72. India CRISPR Screening Library Sales Value by Application (%), 2025 vs 2032
Figure 73. CRISPR Screening Library Value Chain
Figure 74. CRISPR Screening Library Cost Structure
Figure 75. Channels of Distribution (Direct Sales, and Distribution)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What was the global market size of CRISPR Screening Library in 2032?
The global market size of CRISPR Screening Library in 2032 was 583 Million USD.
Which companies rank high in the global CRISPR Screening Library market?
Which region is expected to have the highest market share?
What was the global market size of CRISPR Screening Library in 2026?
What is the annual compound growth rate of the global CRISPR Screening Library market size from 2026 to 2032?
Related Reports
Global CRISPR Screening Library Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global CRISPR Screening Library market size was US$ 218 million in 2025 and is forecast to reach a readjusted size of US$ 583 million by 2032 with a CAGR of 15.0% during the forecast period 2026-2032.
Published Date: 2026-07-19
Pages: 120
USD 4250.00
(Single User License)
Global CRISPR Screening Library Market Outlook, In‑Depth Analysis & Forecast to 2032
The global CRISPR Screening Library market is projected to grow from US$ 218 million in 2025 to US$ 583 million by 2032, at a CAGR of 15.0% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-07-19
Pages: 135
USD 4900.00
(Single User License)
Global CRISPR Screening Library Market Research Report 2026
The global CRISPR Screening Library market was valued at US$ 218 million in 2025 and is anticipated to reach US$ 583 million by 2032, at a CAGR of 15.0% from 2026 to 2032.
Published Date: 2026-07-19
Pages: 112
USD 2900.00
(Single User License)
Global CRISPR Screening Library Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global CRISPR Screening Library market size was US$ 218 million in 2025 and is forecast to reach a readjusted size of US$ 583 million by 2032 with a CAGR of 15.0% during the forecast period 2026-2032.
Published: 2026-07-19
Pages: 120
USD 4250.00 (Single User License)Global CRISPR Screening Library Market Outlook, In‑Depth Analysis & Forecast to 2032
The global CRISPR Screening Library market is projected to grow from US$ 218 million in 2025 to US$ 583 million by 2032, at a CAGR of 15.0% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-07-19
Pages: 135
USD 4900.00 (Single User License)Global CRISPR Screening Library Market Research Report 2026
The global CRISPR Screening Library market was valued at US$ 218 million in 2025 and is anticipated to reach US$ 583 million by 2032, at a CAGR of 15.0% from 2026 to 2032.
Published: 2026-07-19
Pages: 112
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now